Triple coronary bypass in a child with homozygous familial hypercholesterolemia

Mehmet Salih Bilal1, Numan Ali Aydemir, Nihat Cine

  • 1Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey. mehmetkaplan@superonline.com

The Heart Surgery Forum
|August 16, 2005
PubMed

Insights

A 12-year-old girl with familial homozygous hypercholesterolemia underwent triple coronary bypass surgery due to severe atherosclerosis. She is now in good condition, managed with lipid-lowering therapy and apheresis.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Medical Genetics

Background:

  • Familial homozygous hypercholesterolemia (HoFH) is a rare genetic disorder causing extremely high cholesterol levels.
  • Severe coronary atherosclerosis in pediatric patients is uncommon but can lead to critical cardiac events.
  • Early diagnosis and aggressive management are crucial for HoFH patients to prevent premature cardiovascular disease.

Observation:

  • A 12-year-old female presented with extremely high total cholesterol (1300 mg/dL) and extensive coronary atherosclerosis.
  • She had a history of successful out-of-hospital cardiopulmonary resuscitation due to a cardiac event.
  • Angiography revealed significant three-vessel disease, including stenosis in the right coronary and left coronary ostia.

Findings:

  • The patient underwent a successful triple coronary bypass procedure using arterial and venous grafts.
  • Grafts included left internal thoracic artery (LITA) to the left anterior descending artery, radial artery to the obtuse marginal artery, and saphenous vein graft to the right posterior descending artery.
  • Post-operative angiography confirmed successful revascularization.

Implications:

  • This case highlights the feasibility and success of coronary artery bypass grafting in pediatric patients with severe HoFH and atherosclerosis.
  • Intensive lipid-lowering therapy combined with weekly lipid apheresis is essential for long-term management.
  • Aggressive surgical and medical interventions can improve outcomes for young patients with this severe genetic lipid disorder.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...